Deutsche Bank Ag\ Codiak Bio Sciences, Inc. Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.24 - $6.96 $21,392 - $66,468	-9,550 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$4.3 - $12.95 $4,377 - $13,183	-1,018 Reduced 9.63%	9,550 $60,000
Q4 2021 Feb 11, 2022	BUY	$10.0 - $16.78 $5,020 - $8,423	502 Added 4.99%	10,568 $118,000
Q3 2021 Nov 04, 2021	SELL	$15.58 - $22.88 $2,664 - $3,912	-171 Reduced 1.67%	10,066 $164,000
Q2 2021 Aug 11, 2021	BUY	$11.72 - $26.81 $78,395 - $179,332	6,689 Added 188.53%	10,237 $190,000
Q1 2021 May 13, 2021	SELL	$13.49 - $31.53 $4,694 - $10,972	-348 Reduced 8.93%	3,548 $53,000
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $30,778 - $125,840	3,896 New	3,896 $126,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.